PPT-Comparative Effectiveness and Safety of Medications for

Adults with Type 2 Diabetes An Update Including New Drugs and 2Drug Combinations First Last Credentials Rationale for Update 2007 first AHRQ publication on comparative effectiveness of oral meds for type 2 DM. 1 Number 87 Pressure Ulcer Risk Assessment and Prevention: Comparative Effectiveness Executive Summary Background Pressure ulcers are dened by the National Pressure Ulcer Advisory Panel (NPUAP) a Prepared for:. Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov. This presentation will:. Show how to choose concurrent, active comparators from the same source population (or justify the use of no-treatment comparisons/ historical comparators/different data sources). Education . for Staff . Medication Management Safety Team . May 2015. High Alert Medications (HAMs. ). Learning Objectives:. Define and identify what High Alert Medications (HAMs) are.. Be aware and understand the risks, errors and adverse events associated with HAMs. . Prepared for:. Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov. Introduction to recombinant activated factor VII (rFVIIa). Process for developing the comparative effectiveness review (CER). D. evelopmental Disabilities. Connecticut Department of Developmental Services. Vincent Covino, Ph.D.. Clinical Director, North Region. Rachel Duzant, Psy.D.. Supervising Psychologist, North Region. Peter Tolisano, Psy.D.. Are Key to . Keeping Kidney Patients Safe. On average, dialysis patients take 6 to 10 different medications each day.. Most dialysis patients report that they only “sometimes” discuss all of their medications with their doctor.. Presented by Robbie L. Sarles. RLS & Associates, Inc.. 12th Annual FTA Drug and Alcohol Program. National Conference. April 18-20, 2017. Background . “You . can feel the effects some over-the-counter medicines can have on your driving for a short time after you take them, or their effects can last for several hours. Presented by Robbie L. Sarles. RLS & Associates, Inc.. 11th Annual FTA Drug and Alcohol Program. National Conference. March 22-24, 2016. Rx/OTC Program. What Is An Effective Rx/OTC Program?. A program that minimizes the associated impairment risks of taking prescription and over-the-counter (OTC) medications while performing transit–related, safety-sensitive functions. implementation of Dolutegravir. Meireles MV. , Pascom ARP, Perini F, Rick F, Benzaken A. . Ministry of Health of Brazil, Department of STI, AIDS and Viral Hepatitis. Acknowledgements. No. . conflicts of interest. Welcome and Introductions. 2. Presentation Goals. To raise your awareness of:. how you can help improve patient safety. safe medication use practices . the value of working with your pharmacist. 3. Topics. Research into practice. Perspectives from a Former “PCORIAN”. Kara Odom Walker, MD, MPH, MSHS, FAAFP. Cabinet Secretary, Department of Health and Social Services. May 15, 2017. An independent research institute authorized by Congress in 2010 and governed by a 21-member Board of Governors representing the entire health care community. Prepared for:. Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov. This presentation will:. Show how to choose concurrent, active comparators from the same source population (or justify the use of no-treatment comparisons/ historical comparators/different data sources). Prepared for:. Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov. Introduction to recombinant activated factor VII (rFVIIa). Process for developing the comparative effectiveness review (CER). . Ron D. Hays, Ph.D.. October 21, 2014 (12:00 – 1:00). 44. th. Presentation of the UCLA Center for Maximizing . Outcomes and Research on Effectiveness (C-MORE). Live Webinar at: . https://uclahs.webex.com/.